GlobeVerge

BostonSight and Hyderabad-based LVPEI have launched a prospective clinical trial to study the mental health effects of PROSE and scleral lenses. The multi-site study will assess patient outcomes and explore whether specialty lenses can improve quality of life and support earlier intervention.
Developments like this can have effects beyond the immediate story.